Computational Study on Receptors Related to Aggressive Conduct

 

Balasankar Karavadi*, Shivashankari S.

Department of Bioinformatics, School of Bio-Chemical Engineering, Sathyabama University, Chennai-600119 India.

 

ABSTRACT:

Investigations of human behavioral hereditary qualities have made it less demanding to comprehend the relative commitments of hereditary qualities and the environment in watched variety in human conduct The genes responsible for the aggressive conduct with the assistance of literature works on the proteins they code were recognized and the elements of these proteins and the pathways in which they are included are additionally analyzed. As indicated by the elements of these receptors it is watched that over articulation of 2 fundamental receptors prompt strange and expanded aggression. This implies inhibiting over expression would be a source of solution to reduce this abnormal behavior. Along these lines ligands are chosen from GeneCards and Malacards of their hindering properties which can go about as antipsychotic specialists, dopamine rivals, serotonin rival and antidepressants. These ligands are then screened in view of the ADMET properties. The outcomes demonstrate that ligands, for example, L-tyrosine, dexmethylphenidate, olanzapine, parozetine, selegiline and loxapine are more ideal to tie with the proteins. These ligands are then docked with the receptors to locate the fitting inhibitors. The connection between the receptors and the ligands are examined, the docking study uncovers that the suitable ligands can be utilized as an answer for aggressive, criminal and rough behavioral changes as it holds the ordinary conduct.

 

 

 

INTRODUCTION:

Studies of human behavioral genetics have made it easier to understand the relative contributions of genetics and the environment in observed variation in human behavior. aggressive conduct has been given significant consideration for over five decades (1). This consideration has been picked up as before claims in U. S. criminal cases established in behavioral hereditary qualities have looked to set up that hereditary changes could be the reason of criminal conduct. These cases and contextual analyses give interfaces between the articulation level of forceful conduct and rate of wrongdoings. MAOA and CDH13 were found to be in charge of forceful conduct and henceforth known as "warrior genes" (2).

 

Numerous other comparative qualities have been observed to be in charge of articulation of forceful.

 

From the exploration thinks about, there were 58 qualities in people recognized to be in charge of any behavioral changes and some are related with changes, for example, forceful conduct, self-destructive conduct, brutality, standoffish conduct and criminal conduct. The competitor qualities were recognized that have close relationship with dopamine and serotonin neuro transmission and in hormone control. Because of its over expression or under articulation, the majority of the behavioral changes happens when proteins that are associated with control of these neurotransmitters are communicated more than the prerequisite it specifically prompts hasty aggression (3).

 

The primary target of this investigation is to recognize the qualities in charge of behavioral changes, for example, animosity, criminal conduct and self-destructive conduct and to break down their proteins and to dock them with the inhibitors (ligands) to restrain the over expression. To distinguish the qualities and their individual proteins identified with based on their functions and pathways. To identify the genes and their respective proteins related to aggression and to study their functions and pathways. To show the proteins with the assistance of the objective arrangement and a format, to approve the models so it can be utilized for docking, Ligands are recognized based on their functions, to screen the ligands in view of ADMET properties, active restricting destinations of the proteins are distinguished and the ligands are docked with the receptors, the associations between docked particles are examined based on different variables like dock score (4).

 

MATERIALS AND METHODS:

The grouping of the 5-hydroxytryptamine receptor 1B and Sodium-dependent dopamine transporter was retrived from Uniprot (5). Since these proteins don't have a structure, homology show building was finished utilizing Phyre2 (6). The displayed structures were approved utilizing Mol honesty, an online server (7). The Metapocket server was utilized to binding sites restricting locales of the protein particles (8). Further, on the premise of high throughput strategy lead particles having greater partiality with the objective protein were acquired from Pubchem and drug bank database (9). Then the structurally similar compounds were obtained using Pubchem database (10). The sdf arrange from pubchem database was changed over smiles notation documentation utilizing Cactus (11) an online smiles converter. Corina (12) was utilized to change over the smiles documentation into a pdb data. Autodock was utilized to investigate particular protein-ligand docked edifices, the buildings were then pictured utilizing Pymol lastly toxicity of the ligand particles were analyzed utilizing ADMET descriptors (13-15).

 

Genes that are in charge of rise in forceful conduct are found from and that give comes about in view of GWAS and CGAS. Around 30 genes are found to participate in this aggression. Half of these qualities add to incautious animosity by polymorphism though alternate qualities specified, contribute their over expression. Therefore according to earlier ideologies it proved that disorders caused by over expression of genes can be controlled by inhibiting those genes using suitable inhibitors. Along these lines, we have picked 2 among them shown in table 1.

 

Table 1. Associated genes and their coding proteins

Gene Symbol	Protein name	Associated phenotype
HTR1B	5-hydroxytryptamine receptor 1B	Aggressive behavior, anger hostility
SLC6A3	Sodium-dependent dopamine  transporter	Pathological violence, serious delinquency and criminal conduct

 

This gene HTR1B codes for G-protein coupled receptor for 5-hydroxytryptamine. It functions as a receptor for various anxiolytic and antidepressant drugs and other psychoactive substances. This receptor regulates the release of 5-hydroxytryptamine, dopamine and acetylcholine in the brain, and thereby affects neural activity, nociceptive processing, pain perception, mood and behavior.

 

Sodium-dependent dopamine transporter is an amine transporter that terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals. Its over expression is rare, is involved in neurodegenerative disorder characterized by infantile onset of parkinsonism and dystonia.

 

Medications for temperament swings and sudden behavioral changes were gathered from GeneCards and MalaCards. Hence these drugs and inhibitors are taken as ligands to be docked with the demonstrated protein structures. An aggregate of 29 ligands are taken and their capacities are contemplated. The elements of these ligands incorporate insane medication, serotonin opponent, bipolar turmoil sedate and is utilized as a part of treatment of norepinephrine and epinephrine.

 

Amisulpride, Aripiprazole, Bupropion, Chlopromazine, Citalopram, Clomipramine, Clozapine, Dexmethylphenidate, Disulfiram, Entacapone, Escitalopram, Fenfluramine, Isocarboxazid, L tryptophan, L tyrosine,Loxapine, Metyrosine, Olanzapine, Paroxetine, Phenelzine, Risperidone, Selegiline, Sertraline, Tertrahydrobiopterin, Tolcapone, Tranylcypromine, Ziprasidone, Moclobemide, Dopamine.All the ligands that are recognized are screened in view of their capacities and ADMET properties. By utilizing ADMET apparatus, the BBB level, assimilation level, dissolvability level, hepatotoxicity, CYP2D6, PPB level can be found. The elements of the considerable number of ligands taken are examined from literature papers and medication related databases.

 

 

(a)

 

(b)

Figure 1 Structures and corresponding Ramachandran plots of

(a)     5 hydroxytryptamine receptor 1B (b) Sodium dependent dopamine transporter.

Figure 1 demonstrates the 3D structures that have been displayed utilizing Phyre 2. The succession of the objective protein and the layout that has the most comparable arrangement are utilized to assemble the objective protein structure. The above figures demonstrate the models of proteins as saw in discovery studio visualize.

 

 

 

Table 2. Favoured regions and allowed regions of the protein models as predicted by Ramachandran plot.

Target Protein	Length	Template	Length	Similarity	Ramachandran plot
					Favoured regions	Allowed regions	Outliers
5 Hydroxytrypta -mine receptor 1B	390	4IAQ_A	403	77%	90.7%	9%	0.3%
Sodium dependent dopamine transporter	620	5XPB_A	640	59%	82.6%	17.4%	0%

 

The above table 2 demonstrates the arrangement length of the objective proteins, the format ID that is chosen in view of the blastp search. It additionally gives the succession length of the layout and the aftereffects of Ramachandran plot. By dissecting the Ramachandran plot for every protein show the measure of favored locales, permitted districts and prohibited areas are recognized, thus approving the displayed structures.

 

Ligands to be used as inhibitors of these proteins are screened using ADMET analysis.

 

The figure 2 speaks to screening of the 29 ligands by ADMET investigation. In this the blue spots speak to the ligand particles. Based on  this ADMET examination, just 7 out of the 29 ligands are found to fulfill the ADMET properties. Alternate ligands are either poisonous or have poor ingestion level.

 

 

 

Figure 2. ADMET screening result of ligands

 

 

LIGANDS OF 5 HYDROXYTRYPTAMINE RECEPTOR 1B

Table 3. Docking results of 5 hydroxytryptamine receptor 1B with the ligands

Ligand	LigScore1	LigScore2	_PLP1	_PLP2	Jain	PMF	DockScore	Lig Int Energy	MWt
Sertraline	1.57	3.77	51.72	65.07	0.08	50.06	45.325	-10.006	383.28
Dexmethylphenidate	3.02	4.3	51.93	56.3	2.88	8.17	38.864	-3.557	214.16
Paroxetine	3.02	3.42	46.59	46.42	0.92	21.29	33.032	-2.751	251.61
L tyrosine	3.2	3.76	34.82	38.26	-0.13	25.08	30.339	-0.575	192.13
Loxapine	1.09	3.42	37.44	33.98	-1.02	24.36	26.616	-1.23	170.1
Olanzapine	0.57	2.92	35.77	34.54	-1.58	19.16	26.6	-1.165	182.11
Selegiline	0.54	3.31	35.33	33.54	0.11	9.22	22.583	-0.574	124.1

 

This table 3 speaks to the docking effects of 5 hydroxytryptamine receptor 1B with the 7 ligands. The 7 ligands that dock the receptor are arranged by their dock score. The above table records the dock score, inner vitality and its sub-atomic weight. The ligand sertraline demonstrates the most noteworthy dock score of 45.325 with an inner vitality of - 10.006 and has a sub-atomic weight of 383.28 g/mol.

 

Table 4. Interacting molecules of 5 hydroxytryptamine receptor 1B and the ligands

Ligand	Dock Score	Amino Acid (Receptor)	Atom		Distance	Internal
			Ligand	Receptor		Energy
Sertraline	45.325	LYS382	N15	HZ2	2.14761
		LYS382	O23	HZ3	2.21683	-10.006
Dexmethylpheni	38.864	LYS79	O2	HZ2	1.9594
-date		LYS382	O4	HZ2	1.85416	-3.557
Paroxetine	33.032	LYS79	O11	HZ2	2.33137	-2.751

 

The table 4 provides information on the molecules of ligands that bind with the binding site of the protein. It also shows the number of H bonds and the distance between the binding molecules. Internal energies of the molecules are also mentioned in the table above.

 

 

(A)                                                                                           (B)

 

 

(C)

Figure 3. Interaction of 5 hydroxytryptamine receptor 1B with (A) Sertraline (B) Dexmethylphenidate (C) Parozetine

 

The figure 3 shows the docking of 5 hydroxytryptamine receptor 1B with the top 3 ligands that have inhibited the receptor with the highest dock score. Sertraline shows the highest dock score of 45.325 whereas dexmethylphenidate and parozetine show dock score of 38.864 and 33.032 respectively. The figures show the binding of the ligand molecules with the binding site of the protein model.

 

LIGANDS OF SODIUM DEPENDENT DOPAMINE TRANSPORTER:

Table 5. Docking results of sodium dependent dopamine transporter and the ligands

Ligand	LigScore1	LigScore2	_PLP1	_PLP2	Jain	_PMF	DockScore	Lig Int Energy	MWt
L tyrosine	2.61	4.32	63.27	55.68	0.52	64.76	38.386	-2.125	192.13
Loxapine	1.99	3.85	59.01	45.73	-0.06	60.45	33.929	-0.914	170.1
Olanzpine	1.25	3.99	61.08	53.6	0.01	61.69	33.522	-1.649	182.11
Selegiline	0.91	3.68	42.03	34.96	-0.51	46.96	28.229	-0.549	124.1
Sertraline	0.98	2.55	80.34	74.1	1.99	87.26	27.198	-6.751	383.28
Dexmethylphenidate	2.48	3.14	59.13	59.18	1.52	73.65	26.968	-2.965	214.16

 

 

This table 5. represents the docking results of sodium dependent dopamine transporter with the 7 ligands. 6 ligands that dock the receptor successfully and are tabulated according to their dock score. The above table lists the dock score, internal energy and its molecular weight. The ligand L tyrosine shows the highest dock score of 38.386 with an internal energy of -2.125 and has a molecular weight of 192.13 g/mol.

 

 

Table  6.  Interacting molecules of sodium dependent dopamine transporter and the ligands

Ligand	Dock Score	Amino		Atom	Distance	Internal
		Acid (Receptor)	Ligand	Receptor		Energy
		ASP191	O14	OD1	3.1937
L tyrosine	38.386	ILE178	N15	O	3.1154	-2.125
		ASP191	N15	OD1	2.72935
Loxapine	33.929	THR400	O10	HG1	2.45309	-0.914
		THR400	N14	HG1	2.05895
Olanzapine	33.522	GLU396	N14	O	2.85261	-1.649
		THR400	N14	OG1	2.60269

 

 

The table 6 provides information on the molecules of ligands that bind with the binding site of the protein. The table shows the number of H bonds and the distance between the binding molecules, internal energies of the molecules, the atoms and the amino acid residues involved in the binding.

 

 

(A)                                                                     (B)

 

(C)

Figure 4. Interaction of sodium dependent dopamine transporter with (A) L tyrosine  (B) Loxapine (C) Olanzapine

 

The figure 4 shows the docking of sodium dependent dopamine transporter with the top 3 ligands that have inhibited the receptor with the highest dock score. Sertraline shows the highest dock score of whereas dexmethylphenidate and parozetine shows second and third highest dock score of respectively. The figures show the binding of the ligand molecules with the binding site of the protein model.

 

SUMMARY AND CONCLUSION:

In this work, genes and their particular proteins that are exclusively in charge of raised and irregular forceful conduct in human. As per past investigations based on the behavioral change, inhibitors can be utilized as a treatment to stop irregular conduct. Inhibitors can be utilized to hinder the ability of the protein just if it’s over expression is in charge of this deformity. Four noteworthy qualities coding certain receptors are considered in charge of this. These proteins are demonstrated and afterward the ligands to hinder these proteins are recognized. The ligands were screened for specific properties. At that point the proteins were docked with the ligands to locate the reasonable inhibitors. interactions between these particles was considered. In this manner the reasonable inhibitors of the two receptors were found.

 

REFERENCES:

1.     Alexis C. Edwards, Kenneth A. Dodge, Shawn J. Latendresse, Jennifer E. Lansford, John E. Bates, Gregory S. Pettit, John P. Budde, Alison M. Goate, Danielle M. Dick, MAOA uVNTR and Early Physical Discipline Interact to Influence Delinquent Behavior, PMC. 2011 51( 6): :679–687.

2.     Anna L. Scotta, Marco Bortolatoa, Kevin Chena, and Jean C. Shiha, Novel monoamine oxidase A knock out mice with human-like spontaneous mutation, PMC. 2012 19( 7) 739–743.

3.     Brunner, H. G, Nelen, M, Breakefield, X. O, Ropers, H. H, van Oost, B. A, Abnormal Behavior Associated with a Point Mutation in the Structural Gene for Monoamine Oxidase A, Science.1993 262(5) 578-580.

4.     Cintia Garai, Takeshi Furuichi , Yoshi Kawamoto, Heungjin Ryu, Miho Inoue-Murayama, Androgen receptor and monoamine oxidase polymorphism in wild bonobo, Meta Gene 2. 2014 2(2) 831–843.

5.     Pundir S, Martin MJ, O'Donovan C UniProt Consortium. UniProt Tools. Current Protocols in  Bioinformatics.2016; pp 1-1.27

6.     Kelley LA, Mezulis S, Yates CM, et al The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols.2015 10(6): 845-858

7.     Arendall WB 3rd, Tempel W, Richardson JS, Zhou W, Wang S et al. A test of enhancing model accuracy in high-throughput crystallography Journal of Structural and Functional Genomics. 2005 6(1): 1-11

8.     Zengming Zhang, Yu Li, Biaoyang Lin et al Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics. 2011 27(15):2083-2088

9.     David S. Wishart, Craig Knox, An Chi Guo et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration Nucleic Acids Research.2006; pp-D668-D672

10.   Sunghwan Kim, Paul A. Thiessen, Evan E. Bolton et al PubChem Substance and Compound databases .Nucleic Acids Research.2016; pp D1202-D1213

11.   Karina Martinez-Mayorga , Terry L. Peppard, José L. Medina-Franco Software and Online Resources: Perspectives and Potential Applications Springer Link.2014 Chapter Fooginformatics; pp 233-248

12.   Stanislav Geidl, Radka Svobodová Vařeková et al How Does the Methodology of 3D Structure Preparation Influence the Quality of pKa Prediction? Journal of Chemical Information and Modeling. 2015 55(6): 1088-1097

13.   Di Muzio, E., Toti, D. & Polticelli, F. DockingApp: a user friendly interface for facilitated docking simulations with AutoDock Vina. Journal of Computer-Aided Molecular Design. 2017 31(2): 1-6

14.   Yuan, S., Chan, H.C. S. and Hu, Z. Using PyMOL as a platform for computational drug design. WIREs Computational Molecular Science.2017 7(2): 1298

15.   Price DA, Blagg J, Jones L, et al Physicochemical drug properties associated with in vivo toxicological outcomes : a review. Expert Opinion Drug Metabolism and Toxicology. 2009 5(8): 921-931

 

 

 

Accepted on 21.01.2018           © RJPT All right reserved

Research J. Pharm. and Tech 2018; 11(5): 1729-1733.